Delivery Order SPE2DB22D2007-SPE2DB25FJ4FG
- Not listed
- The Defense Logistics Agency awarded a $2,217.78 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed price, competitively awarded contract with a completion date of July 21, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,396.34 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a $2,289.58 delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin pens on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement under DLA's Medical Supply Chain operations. The award was issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a...
- The Defense Logistics Agency awarded a $1,036.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin products on May 6, 2025, with completion scheduled for May 7, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery under the company's broader federal contracting relationship with the agency. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,824.80 for NovoLog Mix 70-30 FlexPen 3mL insulin pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,562.48 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin pens. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of NovoLog Mix 70/30 FlexPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,342.84 with an ultimate completion date of September 8, 2025. The contract represents a non-set-aside procurement issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,397 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, with completion scheduled for August 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,541.58 to AmerisourceBergen Drug Corp for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens. The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,299.57 to AmerisourceBergen Drug Corp for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 20, 2025. The delivery will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4FGDelivery Order
The Defense Logistics Agency awarded a $13,061.76 delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin medication on August 21, 2025, with completion targeted for August 22, 2025. This competitively awarded, firm fixed-price contract represents a small-value transaction for pharmaceutical supply to support federal healthcare needs. The contract was fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor serving military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition and its role as a critical vendor within DLA's medical supply chain for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 8/21/25 |